| 摘要 |
A method of treatment of thrombo-embolic conditions in a mammal including man comprising the administration of a non-toxic effective amount of the compound of Formula (I) is described: <IMAGE> (I) Preferred formulations include those suitable for oral, rectal or parenteral administration, and the preferred dose is in the range of from 1 to 120 mg per kg body weight of the compound per day.
|
